Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.

Bielecki A, Roberts J, Mehta R, Raju J.

Nutr Cancer. 2011;63(1):139-50. doi: 10.1080/01635581.2010.516867.

PMID:
21161820
2.

Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta.

Raju J, Bielecki A, Caldwell D, Lok E, Taylor M, Kapal K, Curran I, Cooke GM, Bird RP, Mehta R.

J Nutr. 2009 Mar;139(3):474-81. doi: 10.3945/jn.108.099200. Epub 2009 Jan 13.

3.

Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.

Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL, Clinton SK.

Cancer Res. 1998 Nov 15;58(22):5231-8.

4.

Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.

Cao F, Jin TY, Zhou YF.

Biomed Environ Sci. 2006 Feb;19(1):35-41.

PMID:
16673816
5.

Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model.

Hewitt AL, Singletary KW.

Cancer Lett. 2003 Mar 31;192(2):133-43.

PMID:
12668277
7.

Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion.

Kim MH, Gutierrez AM, Goldfarb RH.

Anticancer Res. 2002 Nov-Dec;22(6C):3811-7.

PMID:
12552999
8.

Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells.

Handayani R, Rice L, Cui Y, Medrano TA, Samedi VG, Baker HV, Szabo NJ, Shiverick KT.

J Nutr. 2006 Jan;136(1):75-82.

9.

Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG.

Cancer Res. 2007 Mar 1;67(5):2141-9.

10.
11.
12.

Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.

Sakamoto T, Horiguchi H, Oguma E, Kayama F.

J Nutr Biochem. 2010 Sep;21(9):856-64. doi: 10.1016/j.jnutbio.2009.06.010. Epub 2009 Oct 3.

PMID:
19800779
13.

Genistein induces growth inhibition and G2/M arrest in nasopharyngeal carcinoma cells.

Han H, Zhong C, Zhang X, Liu R, Pan M, Tan L, Li Y, Wu J, Zhu Y, Huang W.

Nutr Cancer. 2010;62(5):641-7. doi: 10.1080/01635581003605490.

PMID:
20574925
14.

Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.

Liu H, Du J, Hu C, Qi H, Wang X, Wang S, Liu Q, Li Z.

J Nutr Biochem. 2010 May;21(5):390-6. doi: 10.1016/j.jnutbio.2009.01.016. Epub 2009 May 8.

PMID:
19427779
16.
17.

Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells.

Matsumura K, Tanaka T, Kawashima H, Nakatani T.

Anticancer Res. 2008 Mar-Apr;28(2A):709-14.

19.

[Effects of genistein on colon cancer cells in vitro and in vivo and its mechanism of action].

Fan YZ, Li GH, Wang YH, Ren QY, Shi HJ.

Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):4-9. Chinese.

PMID:
20211058
20.

C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.

Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.

Cancer Gene Ther. 2002 May;9(5):453-63.

Supplemental Content

Support Center